Renal Function and Mortality in Patients with Infective Endocarditis
- Author:
Yuji Nishizaki
;
Takuya Watanabe
;
Yasuharu Tokuda
;
Miyuki Futatsuyama
;
Keiichi Furukawa
;
Nobuyoshi Mori
;
Yusuke Tsugawa
;
Heath Yuki
;
Keiichi Tamagaki
;
Fumika Taki
;
Hiroyuki Yamamoto
;
Takafumi Ohiwa
;
Yasuhiro Komatsu
- Publication Type:Journal Article
- Keywords:
infective endocarditis;
chronic kidney disease;
renal function;
mortality
- From:General Medicine
2012;13(1):19-24
- CountryJapan
- Language:English
-
Abstract:
Objectives: Infective endocarditis (IE) has an extremely poor prognosis unless appropriate treatment is received. Hemodialysis patients with IE show higher rates of morbidity and mortality in comparison with non-dialysis patients with IE. We focused on hemodialysis patients, as well as patients in other stages of chronic kidney disease. We sought to assess the relationship between renal function and mortality in patients with IE.
Methods: We carried out a retrospective cohort study on 45 consecutive patients with IE in an urban teaching hospital between November 2003 and August 2008. We collected demographic and clinical data as well as pre- and post-discharge outcomes. Patients were subdivided into four groups according to their eGFR level at admission: A: eGFR≧60 ml/min/1.73 m2 (n=23); B: eGFR 30-59 ml/min/1.73 m2 (n=15); C: eGFR<30 ml/min/1.73 m2 (n=3); and, D: dialysis patients (n=3). It was not possible to determine the outcome status of one patient. The Trend Test was used to evaluate the association between renal function and mortality.
Results: There were 29 male and 16 female patients with IE and the mean age was 67.9+-17.6 (SD). There were 10 diabetic patients (22%). Thirty-nine patients (84%) were either discharged or transferred to another hospital. Seven patients (16%) died: two (9%) Group A patients; three (20%) Group B patients; no Group C patients; and, two (67%) Group D patients. Patients with lower eGFR had higher mortality rates (Trend Test, P=0.046).
Conclusion: We presume a trend towards a higher mortality rate in conjunction with advancing CKD stage.
